ストックスクリーナーアプリを入手
100.41
0.02%
0.02
アフターアワーズ：
102.00
1.59
+1.58%
Axsome Therapeutics Inc (AXSM) 最新ニュース
Axsome Therapeutics Inc.’s Price Action Aligns with Quant SignalsTriple Digit Return Stock Predictions Released - metal.it
Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
What makes Axsome Therapeutics Inc. stock price move sharplyStock Strategy Planner To Watch Now - jammulinksnews.com
Envestnet Asset Management Inc. Sells 10,086 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics (AXSM) to Release Earnings on Monday - MarketBeat
Why is Axsome Therapeutics Inc. stock attracting strong analyst attentionAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
Royce & Associates LP Sells 6,743 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
What catalysts could drive Axsome Therapeutics Inc. stock higher in 2025Invest confidently with real-time data analysis - jammulinksnews.com
Does Axsome Therapeutics Inc. stock perform well during market downturnsGet timely alerts on market opportunities - jammulinksnews.com
Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Cwm LLC Trims Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Y Intercept Hong Kong Ltd Makes New $1.49 Million Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
How strong is Axsome Therapeutics Inc. company’s balance sheetFree Market Dynamics Reports - jammulinksnews.com
Axsome Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Stock Market Query - metal.it
Published on: 2025-07-27 23:41:07 - jammulinksnews.com
Is Axsome Therapeutics Inc. stock overvalued or undervaluedDynamic profit expansion - jammulinksnews.com
When is Axsome Therapeutics Inc. stock expected to show significant growth - jammulinksnews.com
How does Axsome Therapeutics Inc. generate profit in a changing economyUnprecedented profit potential - jammulinksnews.com
Knights of Columbus Asset Advisors LLC Sells 4,957 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Q3 EPS Estimate for Axsome Therapeutics Raised by Analyst - MarketBeat
Axsome Therapeutics: Navigating Setbacks with a Strong Pipeline and Analyst Confidence - AInvest
Axsome: Some Recent Setbacks, Some Recent Wins — Still A Buy (NASDAQ:AXSM) - Seeking Alpha
Axsome Therapeutics (NASDAQ:AXSM) Shares Down 5.6%Here's Why - MarketBeat
Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline - ADVFN Brasil
Why Axsome Therapeutics Inc. stock is on top investor watchlistsSuperior stock selection - jammulinksnews.com
What analysts say about Axsome Therapeutics Inc. stockOutstanding capital growth - Autocar Professional
Axsome Therapeutics Inc. Stock Analysis and ForecastRapid growth trajectories - PrintWeekIndia
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stake Raised by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. - MarketBeat
RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail
New York State Common Retirement Fund Has $3.92 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Is Axsome Therapeutics Inc. stock overhyped or has real potentialUnstoppable trading performance - jammulinksnews.com
How high can Axsome Therapeutics Inc. stock price go in 2025Breakthrough investment results - jammulinksnews.com
How To Trade (AXSM) - news.stocktradersdaily.com
Axsome Therapeutics Settles SUNOSI (Solriamfetol) Patent Litigation With Hetero Labs Ltd. - 富途牛牛
Is This Stock a Buy After Soaring by 20% in 1 Day? - AOL.com
2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now - MSN
Legato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today - 富途牛牛
Is Axsome Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional
Leerink Partners Keeps Bullish Stance on Axsome Therapeutics with Buy Rating - AInvest
Lindbrook Capital LLC Cuts Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Optimistic Outlook for Axsome Therapeutics: Promising Pipeline and Potential Sales Growth Drive Buy Rating - TipRanks
Axsome Therapeutics Breaks Below 200-Day Moving AverageNotable for AXSM - Nasdaq
What drives Axsome Therapeutics Inc. stock priceUnprecedented profit potential - jammulinksnews.com
Readystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - The Globe and Mail
Axsome Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada
10.28%
2.59%
大文字化:
|
ボリューム (24 時間):